Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors

[1]  R. Friedrich,et al.  Hyaluronan in intra‐operative edema of NF1‐associated neurofibromas , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  A. Folpe,et al.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems , 2012, Acta Neuropathologica.

[3]  N. Ishiguro,et al.  Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo , 2011, British Journal of Cancer.

[4]  V. Kosma,et al.  Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma , 2010, BMC Cancer.

[5]  V. Hascall,et al.  Deficiency in the Serum-Derived Hyaluronan-Associated Protein-Hyaluronan Complex Enhances Airway Hyperresponsiveness in a Murine Model of Asthma , 2010, International Archives of Allergy and Immunology.

[6]  A. Lazar,et al.  Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways , 2009, Expert Reviews in Molecular Medicine.

[7]  B. Maria,et al.  Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. , 2009, Cancer research.

[8]  Wei-Lien Wang,et al.  Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome , 2009, Annals of surgery.

[9]  Y. Shimoyama,et al.  Differential expression of angiogenic factors in peripheral nerve sheath tumors , 2008, Clinical & Experimental Metastasis.

[10]  M. Kramer,et al.  Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. , 2008, Cancer research.

[11]  E. Itoi,et al.  Clinical Relevance of Pathological Grades of Malignant Peripheral Nerve Sheath Tumor: A Multi-Institution TMTS Study of 56 Cases in Northern Japan , 2007, Annals of Surgical Oncology.

[12]  C. Mussi,et al.  Malignant peripheral nerve sheath tumors , 2006, Cancer.

[13]  A. Ferrari,et al.  Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  N. Ishiguro,et al.  Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. , 2005, Experimental cell research.

[15]  N. Kanomata,et al.  Hyaluronan synthase expression in pleural malignant mesotheliomas , 2005, Virchows Archiv.

[16]  K. Kimata,et al.  Hyaluronan synthase expression in ovarian cancer. , 2004, Oncology reports.

[17]  B. Toole,et al.  Hyaluronan: from extracellular glue to pericellular cue , 2004, Nature Reviews Cancer.

[18]  T. Hasegawa,et al.  Low grade malignant peripheral nerve sheath tumour: varied cytological and histological patterns , 2003, Journal of clinical pathology.

[19]  Shayn E Armstrong,et al.  Measurement of high-molecular-weight hyaluronan in solid tissue using agarose gel electrophoresis. , 2002, Analytical biochemistry.

[20]  A. Ferrari,et al.  Malignant vascular tumors in children and adolescents: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. , 2002, Medical and pediatric oncology.

[21]  D. Gutmann,et al.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. , 2002, Cancer research.

[22]  Lilly Y. W. Bourguignon,et al.  Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.

[23]  L. Niskanen,et al.  Hyaluronan expression in differentiated thyroid carcinoma , 2002, The Journal of pathology.

[24]  M. Tammi,et al.  Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism* , 2001, The Journal of Biological Chemistry.

[25]  F. Gao,et al.  Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. , 2001, Cancer research.

[26]  A. Tominaga,et al.  Reticular erythematous mucinosis syndrome with an infiltration of factor XIIIa+ and hyaluronan synthase 2+ dermal dendrocytes , 2001, The British journal of dermatology.

[27]  V. Kosma,et al.  Prognostic value of hyaluronan expression in non‐small‐cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma , 2001, International journal of cancer.

[28]  Y. Nishida,et al.  Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. , 2000, Osteoarthritis and cartilage.

[29]  V. Kosma,et al.  Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. , 2000, The American journal of pathology.

[30]  P. Lenas,et al.  Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties* , 1999, The Journal of Biological Chemistry.

[31]  J. Friedman.  Epidemiology of neurofibromatosis type 1. , 1999, American journal of medical genetics.

[32]  V. Kosma,et al.  Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate , 1999, British Journal of Cancer.

[33]  B. Scheithauer,et al.  Malignant peripheral nerve sheath tumor: analysis of treatment outcome. , 1998, International journal of radiation oncology, biology, physics.

[34]  V. Kosma,et al.  Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. , 1998, Cancer research.

[35]  B. Toole,et al.  Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.

[36]  J. Fraser,et al.  Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.

[37]  C. Moran,et al.  Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases. , 1995, The American journal of surgical pathology.

[38]  S. Onodera,et al.  Glycosaminoglycans in Neurofibromas , 1990, The Journal of dermatology.

[39]  B. Scheithauer,et al.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases , 1986, Cancer.

[40]  F. Enzinger,et al.  Soft tissue tumors , 1988 .

[41]  S. Hirohashi,et al.  Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer , 2004, Clinical & Experimental Metastasis.

[42]  V. Kosma,et al.  High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. , 2000, Cancer research.

[43]  S. Vandenberg,et al.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases , 1993, Cancer.

[44]  F. Bertoni,et al.  Malignant Tumors of the Peripheral Nerves , 1990 .